PAPA, ANNALISA
 Distribuzione geografica
Continente #
NA - Nord America 232
EU - Europa 92
AS - Asia 90
SA - Sud America 5
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 421
Nazione #
US - Stati Uniti d'America 231
SG - Singapore 70
IT - Italia 52
GB - Regno Unito 12
SE - Svezia 12
CN - Cina 10
CZ - Repubblica Ceca 6
BR - Brasile 5
IN - India 3
JP - Giappone 3
RO - Romania 3
BD - Bangladesh 2
FI - Finlandia 2
NL - Olanda 2
AE - Emirati Arabi Uniti 1
CA - Canada 1
DE - Germania 1
EE - Estonia 1
EU - Europa 1
HK - Hong Kong 1
NO - Norvegia 1
ZA - Sudafrica 1
Totale 421
Città #
Singapore 48
Chandler 31
Santa Clara 16
Milan 12
Lawrence 11
London 11
Princeton 11
Chicago 10
Wilmington 9
Rome 8
Ashburn 6
Des Moines 6
Olomouc 6
Rende 4
Guangzhou 3
Arezzo 2
Assago 2
Boardman 2
Charlotte 2
Horia 2
Lamezia Terme 2
Los Angeles 2
Naples 2
Phoenix 2
Redwood City 2
San Francisco 2
Shanghai 2
São Paulo 2
The Dalles 2
Tokyo 2
Turku 2
Venezia 2
Atlanta 1
Bartlesville 1
Boston 1
Brooklyn 1
Catania 1
Catanzaro 1
Chennai 1
Columbus 1
Cosenza 1
Council Bluffs 1
Denver 1
Dhaka 1
Dubai 1
Foshan 1
Hanover 1
Hong Kong 1
Johannesburg 1
Koenjiminami 1
Lucknow 1
Luis Eduardo Magalhães 1
Manassas 1
New York 1
Nicholasville 1
Ottawa 1
Patrocínio 1
Poplar 1
Pozzuoli 1
Redmond 1
Santa Fé 1
Schaumburg 1
Seattle 1
Stockholm 1
Verona 1
Zhengzhou 1
Totale 260
Nome #
F-DOPA PET identifies high tumor grade and anaplastic transformation in non-enhancing gliomas 56
Reduction in Global Myocardial Glucose Metabolism in Subjects With 1-Hour Postload Hyperglycemia and Impaired Glucose Tolerance 38
Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery 37
Long-term metabolic evolution of brain metastases with suspected radiation necrosis following stereotactic radiosurgery: longitudinal assessment by F-DOPA PET 35
ROLE OF 18F-DOPA PET/CT IN NON-ENHANCING GLIOMAS 34
Cross-sectional evaluation of FGD-avid polyostotic fibrous dysplasia: MRI, CT and PET/MRI findings 33
Effects of 26 weeks of treatment with empagliflozin versus glimepiride on the myocardial glucose metabolic rate in patients with type 2 diabetes: The randomized, open-label, crossover, active-comparator FIORE trial 30
Fatal pulmonary tumour thrombotic microangiopathy: do typical FDG-PET findings exist? 28
Impaired insulin-stimulated myocardial glucose metabolic rate is associated with reduced estimated myocardial energetic efficiency in subjects with different degrees of glucose tolerance 26
Use of narrative medicine to identify key factors for effective doctor-patient relationships in severe asthma 26
Not all that glitters is COVID! Differential diagnosis of FDG-avid interstitial lung disease in low-prevalence regions 26
Hyperhomocysteinemia in acute iatrogenic hypothyroidism: the relevance of thyroid autoimmunity 25
Volumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI 24
Repeated amino acid PET imaging for longitudinal monitoring of brain tumors 21
Thyro-gastric autoimmunity in patients with differentiated thyroid cancer: a prospective study 21
Metabolic Syndrome Is Associated With Impaired Insulin-Stimulated Myocardial Glucose Metabolic Rate in Individuals With Type 2 Diabetes: A Cardiac Dynamic 18F-FDG-PET Study 13
Totale 473
Categoria #
all - tutte 6.551
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.551


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 3 0 15 0 2 0 0 0 3
2021/202262 0 0 7 26 3 1 2 9 1 5 6 2
2022/2023126 26 1 2 9 20 7 6 12 25 7 9 2
2023/202476 17 6 10 14 3 11 1 0 4 0 9 1
2024/2025146 22 3 3 0 14 31 5 8 12 1 29 18
2025/202633 30 3 0 0 0 0 0 0 0 0 0 0
Totale 473